Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis
Abstract Background CD9 is implicated in cancer progression and metastasis by its role in suppressing cancer cell proliferation and survival. However, the prognostic and clinicopathological significance of CD9 expression is controversial. Therefore, the current meta-analysis was conducted to determi...
Main Authors: | Hyun Min Koh, Bo Gun Jang, Dong Hui Lee, Chang Lim Hyun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02152-y |
Similar Items
-
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
by: Zhenpeng Wang, et al.
Published: (2019-04-01) -
Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis
by: Na Shen, et al.
Published: (2019-09-01) -
NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis
by: Gu Y, et al.
Published: (2019-05-01) -
Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
by: Aseel Kamil Mohammed Al-mosawi, et al.
Published: (2020-04-01) -
Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis
by: Liu XD, et al.
Published: (2016-05-01)